A detailed history of Coastal Investment Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Coastal Investment Advisors, Inc. holds 6,693 shares of ABBV stock, worth $1.2 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
6,693
Previous 9,507 29.6%
Holding current value
$1.2 Million
Previous $1.63 Million 18.96%
% of portfolio
0.63%
Previous 0.32%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$163.84 - $199.33 $461,045 - $560,914
-2,814 Reduced 29.6%
6,693 $1.32 Million
Q2 2024

Jul 15, 2024

BUY
$154.79 - $180.76 $53,712 - $62,723
347 Added 3.79%
9,507 $1.63 Million
Q1 2024

Apr 19, 2024

SELL
$159.82 - $182.1 $72,877 - $83,037
-456 Reduced 4.74%
9,160 $1.67 Million
Q4 2023

Jan 19, 2024

SELL
$137.6 - $154.97 $84,073 - $94,686
-611 Reduced 5.97%
9,616 $1.49 Million
Q3 2023

Oct 20, 2023

SELL
$133.59 - $154.65 $380,998 - $441,061
-2,852 Reduced 21.81%
10,227 $1.52 Million
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $57,111 - $71,071
-431 Reduced 3.19%
13,079 $1.76 Million
Q1 2023

May 05, 2023

BUY
$144.61 - $166.54 $13,159 - $15,155
91 Added 0.68%
13,510 $2.15 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $85,198 - $102,175
616 Added 4.81%
13,419 $2.17 Million
Q3 2022

Oct 27, 2022

BUY
$134.21 - $153.93 $71,802 - $82,352
535 Added 4.36%
12,803 $1.72 Million
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $71,287 - $90,629
-518 Reduced 4.05%
12,268 $1.89 Million
Q1 2022

Apr 13, 2022

BUY
$131.98 - $163.75 $232,680 - $288,691
1,763 Added 15.99%
12,786 $2.07 Million
Q4 2021

Jan 18, 2022

BUY
$107.43 - $135.93 $30,617 - $38,740
285 Added 2.65%
11,023 $1.49 Million
Q3 2021

Oct 18, 2021

BUY
$106.4 - $120.78 $52,136 - $59,182
490 Added 4.78%
10,738 $1.16 Million
Q2 2021

Jul 15, 2021

SELL
$105.21 - $117.21 $36,297 - $40,437
-345 Reduced 3.26%
10,248 $1.15 Million
Q1 2021

Apr 12, 2021

BUY
$102.3 - $112.62 $70,484 - $77,595
689 Added 6.96%
10,593 $1.15 Million
Q4 2020

Jan 13, 2021

BUY
$80.49 - $108.67 $13,924 - $18,799
173 Added 1.78%
9,904 $1.06 Million
Q3 2020

Oct 23, 2020

SELL
$85.91 - $100.83 $204,465 - $239,975
-2,380 Reduced 19.65%
9,731 $852,000
Q2 2020

Jul 16, 2020

BUY
$73.37 - $98.18 $100,737 - $134,801
1,373 Added 12.79%
12,111 $1.19 Million
Q1 2020

Apr 23, 2020

BUY
$64.5 - $97.79 $6,385 - $9,681
99 Added 0.93%
10,738 $818,000
Q4 2019

Feb 05, 2020

BUY
$72.13 - $90.25 $66,143 - $82,759
917 Added 9.43%
10,639 $933,000
Q3 2019

Oct 18, 2019

BUY
$62.98 - $75.72 $109,963 - $132,207
1,746 Added 21.89%
9,722 $738,000
Q2 2019

Aug 01, 2019

SELL
$65.7 - $83.98 $54,005 - $69,031
-822 Reduced 9.34%
7,976 $581,000
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $678,677 - $798,770
8,798 New
8,798 $703,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Coastal Investment Advisors, Inc. Portfolio

Follow Coastal Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.